Schröder H J, Hüneke B, Klug A, Stegner H, Carstensen M, Leichtweiss H P
Universitäts-Frauenklinik, Abt. experimentelle Medizin, Hamburg, Federal Republic of Germany.
Pflugers Arch. 1987 Nov;410(4-5):376-84. doi: 10.1007/BF00586514.
Fetal sheep (n = 13) were chronically instrumented to measure temperatures in the maternal femoral artery (MAT), the amniotic fluid (AFT), the fetal brown adipose tissue (BFT) and the fetal arterial blood (DAT). Cooling loops were inserted into the amniotic cavity. In 4 fetuses osmotic minipumps delivering triiodothyronine (T3) were implanted subcutaneously. One to seven days after surgery the following results were obtained: 1) During control DAT was 0.59 +/- 0.2 degrees C (SD), BFT 0.60 +/- 0.24 degrees C and AFT 0.38 +/- 0.31 degrees C higher than MAT. T3 levels in treated fetuses were 3.4 +/- 1.5 micrograms/l. 2) Infusion of norepinephrine (NE) (5.2 +/- 0.9 micrograms/min per kg fetal body weight) with phentolamine (26.1 +/- 4.3 micrograms/min per kg) into a fetal vein did not change temperatures. 3) During cooling (-53 +/- 15 W) MAT decreased 0.45 +/- 0.3 degrees C, DAT 1.9 +/- 0.39 degrees C, BFT 1.61 +/- 0.52 degrees C and AFT 4.2 +/- 1.8 degrees C. 4) The amniotic fluid was cooled until steady state temperatures were achieved. Then propranolol (26.1 +/- 4.3 micrograms/min per kg) or suxamethonium (3 +/- 1 mg/kg) were introduced into the fetal vein. No consistent and significant changes of temperatures could be detected. It is concluded that 1) lowering the fetal core temperature by 1.6 - 1.9 degrees C and its ambient temperature (AFT) by 4.2 degrees C does not induce shivering or non-shivering thermogenesis suppressible by pharmacologic agents, 2) thermogenesis in fetal brown adipose tissue cannot be induced by NE (with or without supplemention of T3).(ABSTRACT TRUNCATED AT 250 WORDS)
对13只胎羊进行长期仪器植入,以测量母体股动脉(MAT)、羊水(AFT)、胎儿棕色脂肪组织(BFT)和胎儿动脉血(DAT)的温度。将冷却环插入羊膜腔。在4只胎儿中,皮下植入了输送三碘甲状腺原氨酸(T3)的渗透微型泵。术后1至7天获得以下结果:1)在对照期间,DAT比MAT高0.59±0.2℃(标准差),BFT比MAT高0.60±0.24℃,AFT比MAT高0.38±0.31℃。治疗胎儿的T3水平为3.4±1.5微克/升。2) 向胎儿静脉输注去甲肾上腺素(NE)(5.2±0.9微克/分钟·每千克胎儿体重)和酚妥拉明(26.1±4.3微克/分钟·每千克)不会改变温度。3) 在冷却期间(-53±15瓦),MAT下降0.45±0.3℃,DAT下降1.9±0.39℃,BFT下降1.61±0.52℃,AFT下降4.2±1.8℃。4) 将羊水冷却至达到稳态温度。然后将普萘洛尔(26.1±4.3微克/分钟·每千克)或琥珀胆碱(3±1毫克/千克)注入胎儿静脉。未检测到温度的一致且显著变化。得出以下结论:1)将胎儿核心温度降低1.6 - 1.9℃及其环境温度(AFT)降低4.2℃不会诱导可被药物抑制的寒战或非寒战产热;2)去甲肾上腺素(无论是否补充T3)不能诱导胎儿棕色脂肪组织产热。(摘要截于250字)